Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
For INS-1 832/3, agonists were added in HBSS (acute incubations) or complete medium (prolonged incubations), at 11 mM glucose, at the time of seeding into plates
Nausea and Digestive Upset Nausea and other digestive issues are among the most common side effects when starting GLP-1 medications, affecting up to 70% of patients, especially during the initial phase of treatment
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)
Ding L, Zhang J: Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells
Protecting Your Bone Health While Taking GLP-1 Medications If you are taking or considering GLP-1 receptor agonist therapy, several practical strategies can help protect your bone health throughout treatment
